In a follow-up study of renal osteopathy (low-turnover osteopathy/osteopeni
a) in patients on chronic hemodialysis measurement of the activity of the b
one specific alkaline phosphatase has been proven to be apt besides the mea
surement of the intact parathormon levels to assess the possibility to stim
ulate bone formation. The concentrations of osteocalcin and of the procolla
gen type I carboxyterminal propeptide are correlated with the activities of
the bone specific alkaline phosphatase and therefore they allow to assess
the amount of bone formation. Dialysate with low calcium contents of 1.0 -
1.25 mmol/l supports the stimulation of the bone metabolism in patients wit
h low-turnover osteopathy/osteopenia but the activity of the bone specific
alkaline phosphatase (cut-off > 45IU/l) has to be considered. The bone spec
ific alkaline phosphatase activity is a suitable clinical parameter for pre
dicting and recognizing an overstimulation of the bone in due time. The act
ivity of the bone specific alkaline phosphatase is a more sensitive paramet
er than the concentration of the intact parathormon and in low-turnover its
overstimulation should be avoided. Furthermore a vitamin D-3 deficiency ha
s to be corrected. A substitution, no suppression, of calcitriol and of cal
cifediol should be done in low turnover osteopathy/osteopenia.